Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Oral Solution Pharma News

MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Oral Solution

  • 29 September 2025
  • 1 month ago

CDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine Pharma News

CDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine

  • 28 September 2025
  • 1 month ago

CDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in Infants Pharma News

CDSCO Panel Approves Novo Medi Sciences' Phase III Booster Study of PCV13 Pneumococcal Vaccine in Infants

  • 27 September 2025
  • 1 month ago

Bharat Biotech Gets SEC Nod to Begin Phase III Trial of Inactivated Chikungunya Vaccine Pharma News

Bharat Biotech Gets SEC Nod to Begin Phase III Trial of Inactivated Chikungunya Vaccine

  • 26 September 2025
  • 1 month ago

CDSCO Panel Asks Takeda to Submit Full Phase III Data on Dengue Tetravalent Vaccine Pharma News

CDSCO Panel Asks Takeda to Submit Full Phase III Data on Dengue Tetravalent Vaccine

  • 26 September 2025
  • 1 month ago

Zydus Lifesciences Gets CDSCO Panel Nod for Bioavailability Study of Antimalarial Candidate ZY-19489 Pharma News

Zydus Lifesciences Gets CDSCO Panel Nod for Bioavailability Study of Antimalarial Candidate ZY-19489

  • 25 September 2025
  • 1 month ago

Syneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel Pharma News

Syneos Health Asked to Clarify Phase II Tacrolimus Trial Protocol by CDSCO Panel

  • 25 September 2025
  • 1 month ago

CDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses Pharma News

CDSCO Tightens RTI Appeal Timelines, Division Heads to Face Penalties for Lapses

  • 25 September 2025
  • 1 month ago

Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol Pharma News

Intas Pharma Told to Revise Phase I, III Pembrolizumab Trial Protocol

  • 24 September 2025
  • 1 month ago

CDSCO Panel Asks Astellas Pharma to Update Enzalutamide Label After Phase IV Study Pharma News

CDSCO Panel Asks Astellas Pharma to Update Enzalutamide Label After Phase IV Study

  • 24 September 2025
  • 1 month ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.